273 related articles for article (PubMed ID: 24726582)
1. Brain imaging in type 2 diabetes.
Brundel M; Kappelle LJ; Biessels GJ
Eur Neuropsychopharmacol; 2014 Dec; 24(12):1967-81. PubMed ID: 24726582
[TBL] [Abstract][Full Text] [Related]
2. Impaired cerebral blood flow in type 2 diabetes mellitus - A comparative study with subjective cognitive decline, vascular dementia and Alzheimer's disease subjects.
Chau ACM; Cheung EYW; Chan KH; Chow WS; Shea YF; Chiu PKC; Mak HKF
Neuroimage Clin; 2020; 27():102302. PubMed ID: 32521474
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system imaging in diabetic cerebrovascular diseases and white matter hyperintensities.
Bal S; Goyal M; Smith E; Demchuk AM
Handb Clin Neurol; 2014; 126():291-315. PubMed ID: 25410230
[TBL] [Abstract][Full Text] [Related]
4. Microbleeds, lacunar infarcts, white matter lesions and cerebrovascular reactivity -- a 7 T study.
Conijn MM; Hoogduin JM; van der Graaf Y; Hendrikse J; Luijten PR; Geerlings MI
Neuroimage; 2012 Jan; 59(2):950-6. PubMed ID: 21930217
[TBL] [Abstract][Full Text] [Related]
5. Loss of white matter integrity is associated with gait disorders in cerebral small vessel disease.
de Laat KF; Tuladhar AM; van Norden AG; Norris DG; Zwiers MP; de Leeuw FE
Brain; 2011 Jan; 134(Pt 1):73-83. PubMed ID: 21156660
[TBL] [Abstract][Full Text] [Related]
6. Brain atrophy in type 2 diabetes: regional distribution and influence on cognition.
Moran C; Phan TG; Chen J; Blizzard L; Beare R; Venn A; Münch G; Wood AG; Forbes J; Greenaway TM; Pearson S; Srikanth V
Diabetes Care; 2013 Dec; 36(12):4036-42. PubMed ID: 23939539
[TBL] [Abstract][Full Text] [Related]
7. Cerebral atrophy in cerebrovascular disorders.
Jouvent E; Viswanathan A; Chabriat H
J Neuroimaging; 2010 Jul; 20(3):213-8. PubMed ID: 19344366
[TBL] [Abstract][Full Text] [Related]
8. Brain changes underlying cognitive dysfunction in diabetes: what can we learn from MRI?
Biessels GJ; Reijmer YD
Diabetes; 2014 Jul; 63(7):2244-52. PubMed ID: 24931032
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging in cerebral small vessel disease and its use as a surrogate disease marker.
Patel B; Markus HS
Int J Stroke; 2011 Feb; 6(1):47-59. PubMed ID: 21205241
[TBL] [Abstract][Full Text] [Related]
10. Persistent cerebrovascular damage after stroke in type two diabetic rats measured by magnetic resonance imaging.
Ding G; Yan T; Chen J; Chopp M; Li L; Li Q; Cui C; Ning R; Jiang Q
Stroke; 2015 Feb; 46(2):507-12. PubMed ID: 25523056
[TBL] [Abstract][Full Text] [Related]
11. Diabetes increases atrophy and vascular lesions on brain MRI in patients with symptomatic arterial disease.
Tiehuis AM; van der Graaf Y; Visseren FL; Vincken KL; Biessels GJ; Appelman AP; Kappelle LJ; Mali WP;
Stroke; 2008 May; 39(5):1600-3. PubMed ID: 18369167
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional brain changes in middle-aged type 2 diabetic patients: a cross-sectional study.
García-Casares N; Berthier ML; Jorge RE; Gonzalez-Alegre P; Gutiérrez Cardo A; Rioja Villodres J; Acion L; Ariza Corbo MJ; Nabrozidis A; García-Arnés JA; González-Santos P
J Alzheimers Dis; 2014; 40(2):375-86. PubMed ID: 24448784
[TBL] [Abstract][Full Text] [Related]
13. Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT).
Akisaki T; Sakurai T; Takata T; Umegaki H; Araki A; Mizuno S; Tanaka S; Ohashi Y; Iguchi A; Yokono K; Ito H
Diabetes Metab Res Rev; 2006; 22(5):376-84. PubMed ID: 16506272
[TBL] [Abstract][Full Text] [Related]
14. Combined effects of type 2 diabetes and hypertension associated with cortical thinning and impaired cerebrovascular reactivity relative to hypertension alone in older adults.
Tchistiakova E; Anderson ND; Greenwood CE; MacIntosh BJ
Neuroimage Clin; 2014; 5():36-41. PubMed ID: 24967157
[TBL] [Abstract][Full Text] [Related]
15. Structural brain imaging in diabetes: a methodological perspective.
Jongen C; Biessels GJ
Eur J Pharmacol; 2008 May; 585(1):208-18. PubMed ID: 18407264
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of neuroimaging in delirium: predictors, correlates and consequences.
Nitchingham A; Kumar V; Shenkin S; Ferguson KJ; Caplan GA
Int J Geriatr Psychiatry; 2018 Nov; 33(11):1458-1478. PubMed ID: 28574155
[TBL] [Abstract][Full Text] [Related]
18. Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes.
de Bresser J; Tiehuis AM; van den Berg E; Reijmer YD; Jongen C; Kappelle LJ; Mali WP; Viergever MA; Biessels GJ;
Diabetes Care; 2010 Jun; 33(6):1309-14. PubMed ID: 20299484
[TBL] [Abstract][Full Text] [Related]
19. Type 2 diabetes, skin autofluorescence, and brain atrophy.
Moran C; Münch G; Forbes JM; Beare R; Blizzard L; Venn AJ; Phan TG; Chen J; Srikanth V
Diabetes; 2015 Jan; 64(1):279-83. PubMed ID: 25053588
[TBL] [Abstract][Full Text] [Related]
20. Relationship between cerebral blood flow and later cognitive decline in hypertensive patients with cerebral small vessel disease.
Kitagawa K; Oku N; Kimura Y; Yagita Y; Sakaguchi M; Hatazawa J; Sakoda S
Hypertens Res; 2009 Sep; 32(9):816-20. PubMed ID: 19575014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
